Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sonja Henne
Observed name:
Henne, Sonja
Institution:
Ludwig-Maximilians-Universität München
Observed institutions:
German Center for Infection Research,
Ludwig-Maximilians-Universität München
OpenAlex ID:
A5085191476
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
2016
·
Martin J Boeree
, Norbert Heinrich
, et al.
·
The Lancet Infectious Diseases
·
414
PDF
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
2015
·
Norbert Heinrich
, Rodney Dawson
, et al.
·
Journal of Antimicrobial Chemotherapy
·
99
Protein binding of rifampicin is not saturated when using high-dose rifampicin
2018
·
Carlijn H C Litjens
, Rob E Aarnoutse
, et al.
·
Journal of Antimicrobial Chemotherapy
·
24
PDF
Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
2013
·
Patrick Phillips
, Michael Hoelscher
, et al.
·
Trials
PDF
Worte über Werte inspirierende Zitate und Denkanstöße
·
Henne, Sonja
PDF
Show more works
View as search
Works count:
5
Citation count:
537
H-index:
3
I10-index:
3
Year
Topic
Type